Inhibitory control and its modification in spider phobia – study protocol for an antisaccade training trial

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

ISRCTN12918583

Funding Statement

The study is funded by the DGPs (German Society for Psychology: Biological Psychology and Neuropsychology) and Movisens (Peer-Mentoring-Program, awarded to FB and KR), and the Innovative Medizinische Forschung (IMF) of the medical faculty of the University of Münster (awarded to EJL, grant numbers: ME121805 LE121904). AH is supported by the German Research Foundation (Research Training Group 2493/1: 398510439). Study materials were provided by Iris-Tatjana Kolassa and colleges and the Geneva Affective Picture Database (GAPED). The funders of the study are not involved in the collection, analysis, and interpretation of data.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study protocol was approved by the local Ethics Committee of the University of Siegen (07/2021), Germany (reference number: ER_39_2021). The study was designed in accordance with the Declaration of Helsinki, Good Clinical Practice guidelines, and the SPIRIT reporting guidelines. During the run of the study, ethical, legal, and social aspects are anticipated and addressed. Participants provide written informed consent to the experimental procedure before inclusion in the study. Informed consent is obtained by research assistants conducting the interviews for eligibility. Participation is entirely voluntary, and participants have the right to withdraw their consent at any time. Participant information is pseudonymized and stored on a secure database and can only be accessed by the involved researchers and research assistants.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes